Cite
HARVARD Citation
Chevalier, T. et al. (2021). Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME. Cancer medicine. pp. 3952-3963. [Online].